FDA looks to bring cheaper biosimilar drugs to market faster
2025-10-29 15:56:39 ET
More on Amgen, Teva Pharmaceutical
- Teva Vs. Viatris: Who Will Dominate In President Trump's America?
- Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside
- Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors
- Earnings week ahead: AAPL, MSFT, AMZN, META, GOOG, BA, XOM, CVX, MA, V, PYPL, SOFI, and more
- Amgen, AstraZeneca gets FDA nod for Tezspire
Read the full article on Seeking Alpha
For further details see:
FDA looks to bring cheaper biosimilar drugs to market fasterNASDAQ: SDZXF
SDZXF Trading
0.0% G/L:
$79.90 Last:
1,533 Volume:
$79.90 Open:



